Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options
FETCROJA® (cefiderocol) has received European Commission (EC) marketing authorisation for the treatment of infections due…